Offerpad Solutions Inc.
OPAD Nasdaq Real Estate Agents & Managers (For Others) Financials FY2019βFY2025
What Offerpad Solutions Inc. does
No business description yet.
- Legal name
- Offerpad Solutions Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001193125-26-067147
0001825024
Revenue and margins
Offerpad Solutions Inc. had $568M of revenue in fiscal 2025, down 38.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $65.7M in fiscal 2025, 11.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Offerpad Solutions Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 13.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Offerpad Solutions Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $170M | $97.2M | $76.0M | $43.0M | $26.5M |
| Interest coverage | 1.2x | β2.8x | β5.5x | β2.5x | β2.5x |
| Current ratio | 1.3x | 1.2x | 1.3x | 1.2x | 1.5x |
| Quick ratio | 0.2x | 0.2x | 0.3x | 0.3x | 0.4x |
| Total assets | $1.4B | $825M | $380M | $313M | $155M |
| Total liabilities | $1.1B | $703M | $278M | $265M | $117M |
| Shareholders' equity | $258M | $122M | $102M | $47.7M | $38.2M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 5 / 8 | 3 / 8 | 4 / 8 | 4 / 8 | 4 / 8 |
| Accruals ratio | β | β75.5% | 116.9% | β41.7% | β62.9% | β24.0% | β48.4% |
| Altman Z'' | β | β2.05 | 1.36 | β1.05 | β3.23 | β4.68 | β9.95 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $1.1B | $1.1B | $2.1B | $4.0B | $1.3B | $919M | $568M |
| Gross profit | $74.4M | $87.8M | $208M | $182M | $70.2M | $72.2M | $42.0M |
| Research and development | $7.5M | $7.3M | $10.9M | $12.1M | $7.9M | $4.5M | $3.4M |
| Operating income | β$33.4M | β$13.8M | $19.8M | β$127M | β$104M | β$46.0M | β$33.4M |
| Interest expense | $18.3M | $10.0M | $15.8M | $46.0M | $18.9M | $18.7M | $13.4M |
| Pretax income | β$51.7M | β$23.0M | $6.6M | β$148M | β$117M | β$62.1M | β$45.9M |
| Income tax | $0.3M | $0.2M | $0.2M | $0.4M | $0.2M | $0.0M | $0.4M |
| Net income | β$52.0M | β$23.1M | $6.5M | β$149M | β$117M | β$62.2M | β$46.4M |
| Diluted EPS | β$0.90 | β$0.40 | $0.68 | β$9.09 | β$4.44 | β$2.27 | β$1.50 |
| Diluted shares | 0.06B | 0.06B | 0.01B | 0.02B | 0.03B | 0.03B | 0.03B |
| Cash flow | |||||||
| Cash from operations | β$109M | $155M | β$922M | $305M | $262M | $20.8M | $66.8M |
| Capital expenditure | $1.0M | $2.9M | $13.7M | $1.1M | $0.1M | $5.4M | $1.1M |
| Free cash flow | β$110M | $152M | β$936M | $304M | $262M | $15.4M | $65.7M |
| Depreciation and amortization | $0.4M | $0.4M | $0.5M | $1.0M | $0.7M | $0.6M | $1.0M |
| Stock-based compensation | $1.3M | $1.4M | $3.1M | $8.3M | $7.9M | $8.1M | $2.8M |
| Share buybacks | $10.7M | β | β | β | β | β | β |
| Dividends and buybacks | $10.7M | β | β | β | β | β | β |
| Balance sheet | |||||||
| Cash and short-term investments | $22.9M | $43.9M | $170M | $97.2M | $76.0M | $43.0M | $26.5M |
| Current assets | β | $227M | $1.3B | $814M | $372M | $294M | $132M |
| Current liabilities | β | $190M | $1.1B | $699M | $276M | $251M | $88.8M |
| Inventory | β | $171M | $1.1B | $665M | $277M | $214M | $93.8M |
| Property and equipment, net | β | $8.2M | $5.1M | $5.2M | $4.5M | $9.1M | $14.7M |
| Total assets | β | $236M | $1.4B | $825M | $380M | $313M | $155M |
| Total liabilities | β | $195M | $1.1B | $703M | $278M | $265M | $117M |
| Preferred stock | β | $0.0M | β | β | β | β | β |
| Shareholders' equity | β$122M | β$143M | $258M | $122M | $102M | $47.7M | $38.2M |
| Margins | |||||||
| Gross margin | 6.9% | 8.2% | 10.0% | 4.6% | 5.3% | 7.9% | 7.4% |
| Operating margin | β3.1% | β1.3% | 1.0% | β3.2% | β7.9% | β5.0% | β5.9% |
| EBITDA margin | β3.1% | β1.3% | 1.0% | β3.2% | β7.9% | β4.9% | β5.7% |
| Net margin | β4.8% | β2.2% | 0.3% | β3.8% | β8.9% | β6.8% | β8.2% |
| FCF margin | β10.2% | 14.3% | β45.2% | 7.7% | 19.9% | 1.7% | 11.6% |
| Returns | |||||||
| Return on capital employed | β | β30.2% | 6.9% | β101.0% | β100.7% | β74.2% | β50.6% |
| Return on equity | β | β | 11.3% | β78.3% | β104.8% | β83.2% | β108.0% |
| Return on assets | β | β9.8% | 0.8% | β13.6% | β19.5% | β17.9% | β19.8% |
| Return on tangible equity | β | β | 2.5% | β121.9% | β115.2% | β130.4% | β121.4% |
| Growth | |||||||
| Revenue growth | β | β1.1% | 94.5% | 90.9% | β66.7% | β30.1% | β38.2% |
| Net income growth | β | β | β | β2,400.5% | β | β | β |
| EPS growth | β | β | β | β1,436.8% | β | β | β |
| FCF growth | β | β | β715.5% | β | β14.1% | β94.1% | 326.1% |
| Share count change | β | 0.0% | β83.5% | 71.2% | 61.4% | 3.9% | 13.1% |
| Financial health | |||||||
| Interest coverage | β1.8x | β1.4x | 1.2x | β2.8x | β5.5x | β2.5x | β2.5x |
| Current ratio | β | 1.2x | 1.3x | 1.2x | 1.3x | 1.2x | 1.5x |
| Quick ratio | β | 0.3x | 0.2x | 0.2x | 0.3x | 0.3x | 0.4x |
| Capital allocation | |||||||
| Capex / revenue | 0.1% | 0.3% | 0.7% | 0.0% | 0.0% | 0.6% | 0.2% |
| Stock comp / revenue | 0.1% | 0.1% | 0.1% | 0.2% | 0.6% | 0.9% | 0.5% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 5.0 | 3.0 | 4.0 | 4.0 | 4.0 |
| Altman Z'' | β | β2.0 | 1.4 | β1.0 | β3.2 | β4.7 | β10.0 |
| Accruals ratio | β | β75.5% | 116.9% | β41.7% | β62.9% | β24.0% | β48.4% |
Source: SEC EDGAR XBRL filings (CIK 0001825024). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.